Please login to the form below

Not currently logged in
Email:
Password:

Horizon adds AZ’s Galbraith to board

UK genomics company also appoints Susan Searle

Horizon Discovery has appointed two new board members, AstraZeneca's head of oncology R&D Susan Galbraith and Susan Searle, ex-CEO of Imperial Innovations Group.

Susan-Galbraith-Horizon

Galbraith is senior VP and head of oncology innovative medicines at AZ and knows Horizon well thanks to a collaboration between the two companies on personalised cancer treatments.

Targeted therapies were a point of note in a recent PMLiVE interview with Galbraith, where she also discussed the rise of immunotherapies and the potential of drug combinations.

Her past experience includes a period as VP of oncology and clinical biomarkers at Bristol-Myers Squibb.

Searle has a more entrepreneurial background, co-founding the technology venture investment business Imperial Innovations Group, where she spent 11 years as its CEO - during which time the company invested £120m in life science companies.

She also sits on the advisory board for the Technology Strategy Board's Emerging Technologies group.

Darrin Disley, CEO of Horizon, said of Galbraith and Searle: “Both have established highly successful careers in their chosen fields and also have proven leadership and advisory success.

“We believe each will be an invaluable asset to Horizon, and look forward to benefitting from their counsel.”

10th June 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics